marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Akebia Therapeutics Financial Ratios 2011-2024 | AKBA
Annual Financial Ratios Akebia Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-4.9 | -1.5 | -1.3 | -1.2 | -3.2 | -4.7 | -8.5 | -2.7 | -3.2 | -4.3 | - | - | - |
P/S |
1.3 | 0.5 | 1.7 | 1.6 | 2.7 | 3.2 | 3.7 | 240.8 | - | - | - | - | - |
EPS |
-0.3 | -0.5 | -1.7 | -2.8 | -2.4 | -2.5 | -1.8 | -3.6 | -2.3 | -8.0 | -126.9 | -27.8 | - |
EV (Enterprise Value) |
486 M | 401 M | 664 M | 647 M | 1.12 B | 925 M | 828 M | 414 M | 156 M | 132 M | -17.3 M | 3.28 M | - |
EBITDA per Share |
-0.24 | -0.43 | -1.58 | -2.71 | -2.09 | -1.5 | -1.82 | -3.61 | -2.32 | -2.46 | - | - | - |
EV/EBITDA |
-2.4 | -1.0 | -3.3 | -3.3 | -7.4 | -1.3 | -2.3 | -3.3 | - | - | - | ||
PEG |
0.27 | 0.12 | 0.16 | -0.11 | 0.05 | -0.28 | -0.17 | 0.05 | -0.04 | 0.01 | - | - | - |
P/B |
-8.4 | 26.9 | 4.8 | 1.9 | 2.3 | 1.1 | 5.5 | 5.4 | 1.5 | 1.5 | - | - | - |
P/CF |
-11.0 | -1.9 | -1.4 | -4.3 | -3.4 | -6.7 | -11.3 | 6.7 | -3.7 | -5.7 | - | - | - |
ROE % |
169.78 | -1801.64 | -381.07 | -157.49 | -70.84 | -22.58 | -64.45 | -199.28 | -46.35 | -35.58 | - | - | - |
ROA % |
-21.48 | -26.46 | -53.28 | -59.75 | -36.26 | -14.41 | -21.12 | -45.22 | -42.48 | -33.37 | - | - | - |
ROCE % |
151.24 | -1544.53 | -357.40 | -154.62 | -50.84 | -24.38 | -36.34 | -73.39 | -46.93 | -36.44 | - | - | - |
Current Ratio |
0.9 | 1.0 | 1.2 | 1.6 | 1.5 | 1.8 | 2.5 | 2.6 | 11.9 | 16.0 | - | - | - |
DSO |
74.6 | 57.3 | 67.6 | 40.7 | 42.3 | 29.3 | 70.2 | 8042.6 | - | - | - | - | - |
DIO |
91.7 | 124.1 | 118.3 | 109.2 | 292.2 | 5368.1 | - | - | - | - | - | - | - |
DPO |
80.4 | 110.1 | 90.7 | 49.6 | 98.5 | 2010.9 | - | - | - | - | - | - | - |
Operating Cycle |
166.3 | 181.4 | 185.9 | 149.9 | 334.5 | 5397.4 | - | - | - | - | - | - | - |
Cash Conversion Cycle |
86.0 | 71.4 | 95.2 | 100.3 | 236.1 | 3386.5 | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Akebia Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.1 | -0.04 | - | -0.08 | -0.06 | -0.14 | - | -0.29 | 0.16 | -0.35 | - | -0.34 | -0.51 | -0.45 | -0.6 | -0.42 | -1.28 | -0.47 | -0.79 | -0.46 | -0.49 | -0.62 | -0.87 | -0.46 | -0.6 | -0.48 | 0.33 | -0.49 | -0.53 | -1.15 | -0.99 | -0.96 | -0.95 | -0.7 | -0.66 | -0.68 | -0.4 | -0.53 | -0.52 | -0.47 | -0.39 | -43.37 | -13.92 | -11.92 | -103.19 | -3.09 | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.02 | - | - | -0.02 | - | -0.09 | - | -0.23 | 0.23 | -0.28 | - | -0.26 | -0.44 | -0.36 | -0.59 | -0.4 | -1.27 | -0.46 | -0.8 | -0.47 | -0.5 | -0.65 | -1.3 | -0.48 | -0.62 | -0.5 | 0.31 | -0.51 | -0.54 | -1.16 | -0.99 | -0.95 | -0.96 | -0.71 | -0.65 | -0.68 | -0.41 | -0.54 | -0.52 | -0.49 | -0.4 | -4.45 | -4.48 | -7.38 | -6.18 | -5.41 | - | - | - | - | - | - | - | - |
ROE % |
138.69 | 140.61 | 261.11 | -393.89 | -1085.64 | -1077.35 | -844.04 | -887.46 | -275.88 | -373.40 | -123.50 | -158.63 | -139.43 | -162.86 | -154.86 | -143.66 | -133.27 | -77.03 | -70.84 | -56.35 | -46.62 | -37.24 | -28.34 | -6.23 | -21.01 | -33.21 | -60.10 | -128.35 | -162.78 | -197.74 | -199.28 | -158.85 | -120.42 | -76.06 | -46.35 | -41.15 | -35.27 | -34.43 | -35.58 | -20.94 | -8.99 | 0.56 | 10.36 | 5.68 | 2.72 | 0.49 | - | - | - | - | - | - | - | - |
ROA % |
-25.90 | -20.63 | -20.04 | -32.45 | -38.69 | -28.73 | -18.51 | -28.40 | -25.88 | -45.00 | -34.53 | -48.03 | -47.45 | -61.17 | -59.53 | -58.28 | -56.04 | -36.30 | -36.26 | -30.04 | -25.57 | -21.45 | -18.08 | -7.80 | -11.53 | -14.02 | -20.23 | -37.10 | -42.84 | -48.85 | -45.22 | -46.50 | -48.03 | -43.59 | -42.48 | -37.93 | -32.72 | -32.11 | -33.36 | -41.18 | -43.63 | -44.93 | -37.98 | -20.83 | -9.96 | -1.79 | - | - | - | - | - | - | - | - |
ROCE % |
116.80 | 125.55 | 240.39 | -369.91 | -1013.29 | -989.03 | -776.46 | -816.48 | -246.20 | -349.45 | -115.81 | -150.30 | -133.74 | -158.51 | -152.03 | -141.57 | -132.27 | -77.16 | -72.52 | -62.66 | -52.88 | -43.41 | -28.02 | -1.92 | -17.26 | -29.72 | -62.55 | -130.32 | -163.71 | -198.78 | -200.32 | -159.78 | -121.69 | -76.87 | -46.96 | -41.84 | -36.03 | -35.25 | -36.45 | -21.38 | -9.00 | 0.99 | 12.54 | 7.66 | 4.48 | 2.03 | - | - | - | - | - | - | - | - |
Current Ratio |
0.8 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.0 | 1.0 | 1.1 | 1.1 | 1.2 | 1.3 | 1.4 | 1.5 | 1.6 | 1.6 | 1.6 | 1.6 | 2.0 | 2.0 | 2.0 | 2.0 | 2.8 | 2.8 | 2.8 | 2.8 | 1.5 | 1.5 | 1.5 | 1.5 | 1.3 | 1.3 | 1.3 | 1.3 | 12.0 | 12.0 | 12.0 | 12.0 | 16.1 | 16.1 | 16.1 | 16.1 | 8.9 | 8.9 | 8.9 | 8.9 | - | - | - | - | - | - | - | - |
DSO |
75.5 | 72.2 | - | 45.8 | 30.2 | 66.0 | - | 98.4 | 52.9 | 85.4 | - | 79.3 | 60.6 | 54.2 | - | 40.9 | 27.2 | 33.9 | - | 38.6 | 35.2 | 34.9 | - | 28.6 | 31.2 | 50.5 | - | 75.6 | 109.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
142.9 | 105.9 | - | 99.7 | 109.6 | 98.8 | - | 95.7 | 195.4 | 113.0 | - | 204.8 | 71.9 | 139.5 | 88.0 | 183.5 | 31.9 | 292.0 | 278.3 | 277.5 | 281.9 | 336.6 | 1342.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
76.0 | 66.2 | - | 52.7 | 64.3 | 71.7 | - | 23.5 | 47.8 | 77.2 | - | 202.6 | 63.0 | 94.7 | 59.6 | 124.2 | 21.6 | 132.6 | 93.8 | 93.5 | 95.0 | 119.7 | 502.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
218.4 | 178.1 | - | 145.4 | 139.8 | 164.0 | - | 194.1 | 248.3 | 198.4 | - | 284.1 | 132.4 | 193.7 | 88.0 | 224.3 | 59.1 | 325.9 | 278.3 | 316.0 | 317.0 | 371.5 | 1342.0 | 28.6 | 31.2 | 50.5 | - | 75.6 | 109.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
142.4 | 111.8 | - | 92.7 | 75.5 | 92.3 | - | 170.6 | 200.6 | 121.1 | - | 81.5 | 69.4 | 99.0 | 28.4 | 100.1 | 37.5 | 193.3 | 184.5 | 222.5 | 222.0 | 251.8 | 839.3 | 28.6 | 31.2 | 50.5 | - | 75.6 | 109.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency